0.1763

4.26% 0.0072

VolitionRX Ltd (VNRX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$0.1691

Aprire:

$0.1652

Volume 24 ore:

405.71K

Relative Volume:

0.38

Capitalizzazione di mercato:

$5.30M

Reddito:

$2.47M

Utile/perdita netta:

$-24.73M

Rapporto P/E:

-0.0418

EPS:

-4.213

Flusso di cassa netto:

$-20.36M

1 W Prestazione:

-2.11%

1M Prestazione:

-28.62%

6M Prestazione:

-93.88%

1 anno Prestazione:

-97.93%

Intervallo 1D:

$0.1652

$0.1783

Intervallo di 1 settimana:

$0.1564

$0.1819

Portata 52W:

$0.1564

$9.60

VolitionRX Ltd Stock (VNRX) Company Profile

Nome

VolitionRX Ltd

Settore

Healthcare (1051)

Industria

Medical Devices (142)

Telefono

646 650 1351

Indirizzo

No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX

Dipendente

Cinguettio

@VolitionRx

Prossima data di guadagno

2026-11-12

Ultimi documenti SEC

VNRX's Discussions on Twitter

Compare VNRX vs ABT, MDT, SYK, BSX, EW

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
VNRX VolitionRX Ltd	0.1763	5.30M	2.47M	-24.73M	-20.36M	-4.213
ABT Abbott Laboratories	103.45	179.00B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	95.94	122.71B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	308.26	118.24B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	45.42	65.83B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	89.92	51.83B	6.30B	1.07B	1.09B	1.8406

VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-04-08	Iniziato	H.C. Wainwright	Buy
2023-02-01	Downgrade	The Benchmark Company	Buy → Hold
2022-02-17	Ripresa	Cantor Fitzgerald	Overweight
2021-03-10	Iniziato	Cantor Fitzgerald	Overweight
2018-05-16	Iniziato	Maxim Group	Buy
2018-05-14	Reiterato	The Benchmark Company	Buy
2016-09-07	Reiterato	Rodman & Renshaw	Buy
2016-02-01	Iniziato	Rodman & Renshaw	Buy

Mostra tutto

VolitionRX Ltd Borsa (VNRX) Ultime notizie

Oct 21, 2026

Nasdaq cuts target for VolitionRx stock to USD 13.89 from USD 16.83 - AD HOC NEWS

Oct 21, 2026

Sep 30, 2026

Neither party sold shares as VolitionRx (VNRX) retained 284 shares for its commercial chief’s taxes. - Stock Titan

Sep 30, 2026

No shares were sold as VolitionRx (VNRX) retained 608 COO shares for cancellation to cover taxes. - Stock Titan

Sep 30, 2026

Sep 22, 2026

VolitionRx stock faces a data driven trading reset - AD HOC NEWS

Sep 22, 2026

Lagoda Investment Management, L.P. Trims VolitionRX Ltd (VNRX) S - GuruFocus

Sep 22, 2026

Sep 18, 2026

VolitionRx Limited stock edges higher as investors weigh recent results - AD HOC NEWS

Sep 18, 2026

Sep 17, 2026

VolitionRx Limited Shares Further Details On The Official Launch Of The DETECSEPS Project On The Early Detection Of Sepsis - marketscreener.com

Sep 17, 2026

VolitionRx joins France sepsis detection consortium By Investing.com - Investing.com Nigeria

Sep 17, 2026

VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France - PR Newswire

Sep 17, 2026

VolitionRx Participates in Launch of DETECSEPS Program in France - PR Newswire

Sep 17, 2026

A €6.3 million French program will test one blood marker to spot sepsis early - Stock Titan

Sep 17, 2026

VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France - Nasdaq

Sep 17, 2026

Sep 16, 2026

One manager now reports nearly 6% of VolitionRx (NYSE: VNRX) - Stock Titan

Sep 16, 2026

Sep 14, 2026

VolitionRx Limited (AMEX:VNRX) Prepays $7.5M Convertible Note, Cuts Dilution Risk - TradingView

Sep 14, 2026

VolitionRx Limited Announces Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note Due May 20, 2027 - Yahoo Finance

Sep 14, 2026

VNRX: VolitionRx Prepays Outstanding Balance on the $7,500,000 Lind Senior Secured Convertible Promissory Note Dated May 20, 2025. Review of Papers, Posters, and Videos Released in Mid-2026. Sysmex Collaboration is the 3rd Recent Agreement in t - Yahoo Finance

Sep 14, 2026

VolitionRX Limited Announces Pre-Payment in F - Moomoo

Sep 14, 2026

Sep 11, 2026

VOLITIONRX LTD SEC Filing (Sep 11, 2026) - Stock Titan

Sep 11, 2026

Sep 10, 2026

Lagoda Investment Management, L.P. Adds VolitionRX Ltd (VNRX) -- Shares Look 98% Undervalued on GF Value - GuruFocus

Sep 10, 2026

VNRX Looks 98.1% Undervalued on GF Value™ Despite Financial Dist - GuruFocus

Sep 10, 2026

A blood-based method detected 95% of stage I and II cancers. - Stock Titan

Sep 10, 2026

Sep 09, 2026

Dilution risk flagged as VolitionRx (NYSE: VNRX) registers more Lind shares for resale - Stock Titan

Sep 09, 2026

Sep 08, 2026

VolitionRx (NYSE: VNRX) details Lind note and warrant stake under 4.99% cap - Stock Titan

Sep 08, 2026

Lagoda Investment Management Elevates VOLITIONRX LTD (AMEX: VNRX) Stake to Activist 13D Filing at 7.4% - kalkinemedia.com

Sep 08, 2026

VNRX - Finviz

Sep 08, 2026

Sep 04, 2026

Fatima Dickey Pushes for Changes at VolitionRx with 7.4% Stake - tradingview.com

Sep 04, 2026

Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validations - Benzinga

Aug 27, 2026

$VolitionRX (VNRX.US)$ - Moomoo

Aug 27, 2026

Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validations - Yahoo Finance

Aug 27, 2026

Aug 26, 2026

VolitionRx revenue rises 112% in H1FY26; shares surge 100% - scanx.trade

Aug 26, 2026

VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets - Yahoo Finance

Aug 26, 2026

Volition's sepsis biomarker predicts 28-day death and kidney treatment needs - Stock Titan

Aug 26, 2026

VNRX Looks 97.8% Undervalued on GF Value™ - GuruFocus

Aug 26, 2026

Aug 17, 2026